Enanta Pharmaceuticals, Inc. (ENTA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
22.38-0.06 (-0.27%)
As of 12:17 PM EDT. Market open.
People also watch:
EPZMXLRNFPRXOMEDOPHT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open22.34
Prev Close22.44
Bid22.42 x 100
Ask22.45 x 200
Day's Range22.05 - 22.62
52wk Range16.75 - 43.08
1y Target EstN/A
Market Cap426.02M
P/E Ratio (ttm)14.80
Beta0.50
Volume63,055
Avg Vol (3m)274,487
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    ETF’s with exposure to Enanta Pharmaceuticals, Inc. : August 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Enanta Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to ENTA-US. Comparing the performance and risk of Enanta Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wireyesterday

    Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences

    Enanta Pharmaceuticals, Inc., , a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R.

  • Enanta Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ENTA-US : August 26, 2016
    Capital Cube4 days ago

    Enanta Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ENTA-US : August 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Enanta Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)